The Costs of Warfarin Underuse and Nonadherence in Patients with Atrial Fibrillation: A Commercial Insurer Perspective

BACKGROUND: Atrial fibrillation (AF) imposes a substantial clinical and economic burden on the U.S. health care system. Despite national guidelines that recommend oral anticoagulation for stroke prevention, the literature consistently reports its underuse in AF patients with moderate to high stroke...

Descripción completa

Detalles Bibliográficos
Autores principales: Casciano, Julian P., Dotiwala, Zenobia J., Martin, Bradley C., Kwong, Winghan Jacqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437466/
https://www.ncbi.nlm.nih.gov/pubmed/23627576
http://dx.doi.org/10.18553/jmcp.2013.19.4.302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437466/
https://www.ncbi.nlm.nih.gov/pubmed/23627576
http://dx.doi.org/10.18553/jmcp.2013.19.4.302

Ejemplares similares